Years of Experience.

 

Our products are present in more than 150  countries all around the World.

OEM Partners.

 

OEM product models.

 

Long expertise in 5 different industries. 

 

MAKE IT SIMPLER

OUR MISSION IS TO BE BY YOUR SIDE.

At Edif, we are committed to delivering exceptional quality and innovation in the
field of automatic analyzers for clinical chemistry and turbidimetric analysis. With
our comprehensive in-house design capabilities, we cover all phases of the
development process, ensuring meticulous attention to detail and the highest
standards of excellence.
Our dedicated team of specialists excels in various domains, including mechanical
design, hardware, firmware, and software. This multidisciplinary approach allows
us to maintain full control over every aspect of our analyzers, resulting in products
that are not only reliable but also meet the most stringent industry requirements.
The development of specific analyzers for third-party firms represents a
consistent part of the current work of the company. This means that we can
customize our analyzers to align with the specific needs and branding
requirements of third-party firms. Our expertise in developing custom analyzers
for external companies has become a significant part of our current work,
showcasing our ability to adapt and cater to diverse market demands. Partner with
us to experience the difference that our expertise and dedication can make in your
analyzer development projects.

       OUR HISTORY

Edif was founded in 1987 as a firm primarily dealing with the development of custom projects for the industrial automation industry. The collaboration with various universities, such as the Università La Sapienza of Rome, and Università Federico II of Napoli has proven its excellence in various engineering fields. During these early years, it became clear that the manufactured production of automated instruments indicates a path for future development.

As the firms’ horizons expanded Edif turned to other applications. Since 1993, in addition to its other commitments, the firm has been heavily involved in the production of automatic analyzers.

Throughout the years, Edif products have been destined for various levels of laboratory use and multiple applications (e.g. chemical chemistry, turbidimetry, immunology, electrophoresis).

MEDICAL

The global medical market size was valued at $57 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12% from 2022 to 2032. Of this index the clinical chemistry analyzers market was valued at $12,1 millions in 2020 and is projected to reach $16,5 million by 2027, growing at a CAGR of 4,5% from 2020 to 2027. Immunoassays play a vital role in disease diagnosis and treatment planning. Thus, an increase in the prevalence of chronic conditions and the introduction of
technologically advanced automated immunoassay analyzers for its diagnosis have fueled the market growth.
Click Here

CHEMICAL AND PHARMACEUTICAL

The global pharmaceutical and chemicals market size was valued $104 billion in 2020 and is predicted to be worth around US$ 197.4 billion by the end of 2030. Pharmaceutical chemicals are basic chemical components used in the production of molecules, pharmaceutical drugs, and other biochemical research.

Click Here

FOOD AND BEVERAGE

The global food and beverages market grew from $5,818.25 billion in 2021 to $6,327.35 billion in 2022 at a compound annual growth rate (CAGR) of 8.7%. The quality of any key ingredient is critical, it is, therefore, fundamental to check the trade fair with qualitative analysis of the raw materials used.

Click Here

VETERINARY

The global veterinary diagnostics market size was valued at $ 6.63 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2030. The increasing expenditure on animal health and subsequently rising demand for veterinary services will largely facilitate overall industry growth.

Click Here

AGRICULTURE

The agriculture market size was valued at $ 6,457 in 2020, and is projected to reach $23,056 million by 2030, growing at a CAGR of 13,4% from 2020 to 2030. Up to 70% of freshwater usage around the World is in agriculture, much of which is for food crops. The quality of any key element is critical to ensure the best quality and safety of our food.

Click Here

 

37 YEARS OF QUALITY.

EXPERIENCE YOU CAN TRUST. 

Edif is constantly working to improve the quality of its products and processes in order to obtain the most important certifications in the IVD market.

WHO WE ARE?

We are a values-driven organization believing in the highest professional standards. Through constant collaborations with our partners, we create enduring value, working every day to inspire innovation in companies of all shapes and industries all around the World.

WHAT DO WE BELIEVE?

We believe in building strong partnerships with our clients rather than selling products only. Day by day by your side we will be part of your success and your achievements. We believe in us: in our companies working together. Together we will build a new way of doing business.

1987-2005

2006-2012

2013-2020

2024

GOVERNMENTAL AIDS
CERTIFICATIONS
PRODUCTS

Years of Experience.

 

Our products are present in more than 150  countries all around the World.

OEM Partners.

 

OEM product models.

 

Long expertise in 5 different industries. 

   

MAKE IT SIMPLER

OUR MISSION IS TO BE BY YOUR SIDE.

At Edif, we are committed to delivering exceptional quality and innovation in the
field of automatic analyzers for clinical chemistry and turbidimetric analysis. With
our comprehensive in-house design capabilities, we cover all phases of the
development process, ensuring meticulous attention to detail and the highest
standards of excellence.
Our dedicated team of specialists excels in various domains, including mechanical
design, hardware, firmware, and software. This multidisciplinary approach allows
us to maintain full control over every aspect of our analyzers, resulting in products
that are not only reliable but also meet the most stringent industry requirements.
The development of specific analyzers for third-party firms represents a
consistent part of the current work of the company. This means that we can
customize our analyzers to align with the specific needs and branding
requirements of third-party firms. Our expertise in developing custom analyzers
for external companies has become a significant part of our current work,
showcasing our ability to adapt and cater to diverse market demands. Partner with
us to experience the difference that our expertise and dedication can make in your
analyzer development projects.

   OUR HISTORY

Edif was founded in 1987 as a firm primarily dealing with the development of custom projects for the industrial automation industry. The collaboration with various universities, such as the Università La Sapienza of Rome, and Università Federico II of Napoli has proven its excellence in various engineering fields. During these early years, it became clear that the manufactured production of automated instruments indicates a path for future development.

As the firms’ horizons expanded Edif turned to other applications. Since 1993, in addition to its other commitments, the firm has been heavily involved in the production of automatic analyzers.

Throughout the years, Edif products have been destined for various levels of laboratory use and multiple applications (e.g. chemical chemistry, turbidimetry, immunology, electrophoresis).

MEDICAL

The global medical market size was valued at $57 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12% from 2022 to 2032. Of this index the clinical chemistry analyzers market was valued at $12,1 millions in 2020 and is projected to reach $16,5 million by 2027, growing at a CAGR of 4,5% from 2020 to 2027. Immunoassays play a vital role in disease diagnosis and treatment planning. Thus, an increase in the prevalence of chronic conditions and the introduction of
technologically advanced automated immunoassay analyzers for its diagnosis have fueled the market growth.
Click Here

CHEMICAL AND PHARMACEUTICAL

The global pharmaceutical and chemicals market size was valued $104 billion in 2020 and is predicted to be worth around US$ 197.4 billion by the end of 2030. Pharmaceutical chemicals are basic chemical components used in the production of molecules, pharmaceutical drugs, and other biochemical research.

Click Here

FOOD AND BEVERAGE

The global food and beverages market grew from $5,818.25 billion in 2021 to $6,327.35 billion in 2022 at a compound annual growth rate (CAGR) of 8.7%. The quality of any key ingredient is critical, it is, therefore, fundamental to check the trade fair with qualitative analysis of the raw materials used.

Click Here

VETERINARY

The global veterinary diagnostics market size was valued at $ 6.63 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2030. The increasing expenditure on animal health and subsequently rising demand for veterinary services will largely facilitate overall industry growth.

Click Here

AGRICULTURE

The agriculture market size was valued at $ 6,457 in 2020, and is projected to reach $23,056 million by 2030, growing at a CAGR of 13,4% from 2020 to 2030. Up to 70% of freshwater usage around the World is in agriculture, much of which is for food crops. The quality of any key element is critical to ensure the best quality and safety of our food.

Click Here

 

35 YEARS OF QUALITY.

EXPERIENCE YOU CAN TRUST. 

Edif is constantly working to improve the quality of its products and processes in order to obtain the most important certifications in the IVD market.

WHO WE ARE?

We are a values-driven organization believing in the highest professional standards. Through constant collaborations with our partners, we create enduring value, working every day to inspire innovation in companies of all shapes and industries all around the World.

WHAT DO WE BELIEVE?

We believe in building strong partnerships with our clients rather than selling products only. Day by day by your side we will be part of your success and your achievements. We believe in us: in our companies working together. Together we will build a new way of doing business.

See our certifications

1987-2005

2006-2012

2013-2020

2024

GOVERNMENTAL AIDS